ClinicalTrials.Veeva

Menu

Effectiveness of Shock Wave Therapy for Upper Limb Spasticity

C

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Status

Enrolling

Conditions

Stroke

Treatments

Device: shock wave therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT04316026
2019/27MAR/151

Details and patient eligibility

About

Introduction: Shock wave therapy (SWT) has a potential interest to treat spasticity. However, the pathophysiology of this treatment remains unknown. Some authors assert that it is effective on spasticity itself, while others suggest that it acts more on fibrosis.

Method: this study will assess the effectiveness of radial SWT to treat wrist and finger flexors stiffness in stroke patients, comparing subacute spastic patients (< 12 months) with chronic patients presenting muscle contractures (> 12 months). Forty-eight stroke patients (24 in the subacute phase and 24 in the chronic phase) will be included. One real and one sham sessions of SWT will be performed with a 2-week interval. The order of the sessions will be randomized. Motor control, stiffness and spasticity will be assessed with clinical and objective measures, just after and just before each session, by a blind assessor. The targeted muscles will be flexor carpi radialis, flexor carpi ulnaris and flexor digitorum profundus, and will be the same for the two session.

Enrollment

48 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • History of cerebral lesion
  • Wrist spasticity ≥ 1+/4 on the Modified Ashworth Scale
  • Wrist spasticity ≥ 2/4 on the Tardieu Scale
  • Passive dorsal extension of the wrist ≥ 10°

Exclusion criteria

  • Botulinum toxin injection in the upper limb in the past three months
  • History of wrist arthrodesis
  • Myopathy
  • Treatment with oral anticoagulants or coagulation disease
  • Tumor or infection of the paretic upper limb

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

48 participants in 2 patient groups

interventional group
Experimental group
Description:
group receiving shock wave therapy
Treatment:
Device: shock wave therapy
control group
Sham Comparator group
Description:
sham shock wave therapy
Treatment:
Device: shock wave therapy

Trial contacts and locations

1

Loading...

Central trial contact

Clara Selves, MD; Gaëtan Stoquart, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems